Malibu Life Holdings Limited (MLHL) fair value: what the stock is really worth
As of Oct 5, 2026: fair value of Malibu Life Holdings Limited $14.28, price $14.00, upside +2.0%, quality 52 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.
How to read this chart
60‑month range $13.90 – $30.80 · fair‑value band $14.28 – $14.34 · the $14.00 price screens below the $14.28 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 3, 2026.
Follow Malibu Life Holdings in your weekly email
Every Wednesday you see whether Malibu Life Holdings is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Malibu Life Holdings Limited is a close ended feeder fund launched and managed by Third Point LLC. The fund invests its entire corpus in Third Point Offshore Fund Ltd. It seeks to benchmark the performance of its portfolio against the S&P 500 TR USD. The fund was formed on July 20, 2007 and is domiciled in Cayman Islands.
Stock analysis
Malibu Life Holdings Limited (MLHL) currently trades at $14.00, while our model-based Fair Value estimate is $14.28, so the stock looks roughly fairly valued today (gap 2.0%).
Show more
Valuation
Bull case: the Asset-Based group reads highest at a median of $14.79 per share, and 3 of the 4 models we run sit above the $14.00 price.
Bear case: the Multiples group reads lowest at $10.78, and 1 of the 4 models stay below the price. Evidence for this calculation is medium.
Scenario range: $14.28 (bear) to $14.34 (bull), the price of $14.00 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 52/100 (solid quality), in the Financial Services sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Malibu Life Holdings Limited reported revenue of $65.2M in FY2025 versus $286M in FY2021, a compound −30.9%/yr. Reported net income was $21.4M in FY2025, compounding −42.8%/yr from FY2021.
Key figures
Market cap $365M · P/E ratio 0.0 · P/S ratio 0.02 · EPS (TTM) $2.93 · Net margin 32.8% · Return on equity 3.8% · Return on assets (EBIT) 2.4% · Operating margin −17.3%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 47 out of 100 (low confidence).
What moves the price
The share trades about 33% below its 52-week high and 1% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Financial Services peers we cover trades at 18% fair-value upside, at 2%, MLHL screens richer than that median.
Fair Value models
Bear $14.28Fair Value $14.28Bull $14.34
Price $14.00 · Upside +2.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then ($2.24 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−9.2%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−13.3%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.6%
Start year 2020 (pandemic). Over 10 years: +6.6% a year
Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.9%
’13
’14
’15
’16
’17
’18
’19
’20
’21
’22
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
−14.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year−14.3%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.−14.3% vs 2.7%, slowing
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.319% → 38%
Start year 2020 (pandemic)
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−14.1%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about −16.1% a year for the price.
Compare Malibu Life Holdings Limited with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Insurance - Reinsurance · 25 stocks
Beats the industry median on 2/8 measures
Overall it trails its industry peers.
Valuation
Quality Score52 · Below median
Fair Value upside+2.0% · Below median
Profitability
Return on equity (TTM)3.8% · Bottom 25%
Return on assets0.4% · Bottom 25%
Net margin (TTM)35.4% · Top 25%
Operating margin (TTM)−17.3% · Bottom 25%
Growth and dividend
Revenue growth−67.6% · Bottom 25%
Valuation Multiplesvs Insurance - Reinsurance median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Malibu Life Holdings Limited Fair Value". https://www.fairvalue-calculator.com/stock/MLHL
Frequently asked questions
Is Malibu Life Holdings Limited (MLHL) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of $14.28 versus a price of $14.00, about +2% upside (fairly valued).
What is the fair value of MLHL?
Our model-based fair value for Malibu Life Holdings Limited is $14.28 (as of Oct 3, 2026), built from audited fundamentals. The current price: $14.00.
What is the quality score of MLHL?
Malibu Life Holdings Limited has a Quality Score of 52/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Malibu Life Holdings Limited (MLHL)?
Our model-based price target is the fair value of $14.28 (as of Oct 3, 2026) from 4 valuation models. Cautious scenario $14.28, optimistic scenario $14.34. It is a calculation from audited fundamentals, not an analyst target.
What is the Malibu Life Holdings Limited stock forecast for 2026?
Our models put fair value at $14.28, about +2% upside versus a price of $14.00 (fairly valued). Cautious scenario $14.28, optimistic scenario $14.34. The calculation is refreshed regularly with new filings.
What is the revenue of Malibu Life Holdings Limited (MLHL)?
Malibu Life Holdings Limited reported trailing-twelve-month revenue of about $60.4M (latest available figure, as of Oct 3, 2026).
What growth is priced into Malibu Life Holdings Limited (MLHL)?
For today's price to be fair in a discounted-cash-flow model, Malibu Life Holdings Limited would have to grow free cash flow by -14.1 % per year for five years (discount rate 11.8 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +4.6 % per year. As of Oct 3, 2026.
What discount rate (WACC) does the fair value of MLHL use?
Our models discount Malibu Life Holdings Limited at 11.8 %: a base by market capitalisation (small), country premium for United Kingdom. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Malibu Life Holdings Limited that is -14.1 % per year a year over ten years, using the same discount rate (11.8 %) and the same formula as our fair value.
How much growth has Malibu Life Holdings Limited (MLHL) delivered so far?
Over the past 5 years revenue at Malibu Life Holdings Limited grew +4.6 % a year. The price currently implies -14.1 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Malibu Life Holdings Limited (MLHL) growing?
The median revenue growth in the sector is +2.2 % a year. That is the yardstick for the growth priced into Malibu Life Holdings Limited (-14.1 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Malibu Life Holdings Limited (MLHL)?
The free-cash-flow yield on the price is 20.73 %: that much free cash flow Malibu Life Holdings Limited produces per unit of market value. When it exceeds the discount rate of our models (11.8 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Malibu Life Holdings Limited (MLHL)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Malibu Life Holdings Limited it is $14.28 per share (as of Oct 3, 2026), against a price of $14.00. It is the blended result of 4 valuation models (cash flow, earnings, asset, dividend).
Is Malibu Life Holdings Limited stock overvalued or undervalued in 2026?
As of Oct 3, 2026, MLHL trades below its calculated fair value: price $14.00, fair value $14.28, a gap of about +2% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of MLHL?
No. The price is what the market pays today ($14.00); the fair value is what the company's own numbers justify ($14.28). For Malibu Life Holdings Limited the two are $0.2800 per share apart. That gap is exactly why we show both numbers side by side.
How much is Malibu Life Holdings Limited worth?
The market values Malibu Life Holdings Limited at about $365M (market capitalisation, as of Oct 3, 2026). Per share that is $14.00; our models calculate a fair value of $14.28 per share.
What do the bullish and bearish scenarios say about MLHL?
Our models span a range for Malibu Life Holdings Limited: cautious scenario $14.28, base $14.28, optimistic $14.34 per share (as of Oct 3, 2026, price $14.00). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of MLHL?
Malibu Life Holdings Limited trades at a price-to-earnings ratio of 0.0 (as of Oct 3, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $14.28 is built from several models across several years.
How solid is the balance sheet of Malibu Life Holdings Limited (MLHL)?
Balance-sheet figures for Malibu Life Holdings Limited (as of Oct 3, 2026): return on equity 3.8%. They feed the Quality Score of 52/100, which measures business quality independently of the share price.
How far is MLHL from its 52-week high?
Malibu Life Holdings Limited trades at $14.00, about 33% below its 52-week high of $20.90 and 1% above the low of $13.90 (as of Oct 5, 2026). Distance from the high says nothing about value: that is what the fair value of $14.28 is for.
Which stocks are comparable to Malibu Life Holdings Limited?
From the same area (Financial Services) we also value MUV2, Swiss Re AG, Hannover Rück SE, Reinsurance Group, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Malibu Life Holdings Limited stock attractive at the current price?
The data as of Oct 3, 2026: price $14.00, calculated fair value $14.28 (+2%), Quality Score 52/100, from 4 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of MLHL calculated?
We run Malibu Life Holdings Limited through 4 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $14.28, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.0 % above its aggregate fair value. Malibu Life Holdings Limited currently trades 2 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Malibu Life Holdings Limited (MLHL)?
The closing price on Oct 5, 2026 was $14.00. Our model-based fair value is $14.28, about +2% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Malibu Life Holdings Limited right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. The models converge in a tight band ($14.28 to $14.34), unusually little disagreement for a valuation. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Key figures of Malibu Life Holdings Limited
How large is the market capitalisation of Malibu Life Holdings Limited (MLHL)?
The market capitalisation of Malibu Life Holdings Limited is $365M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Malibu Life Holdings Limited (MLHL)?
The price-to-sales ratio of Malibu Life Holdings Limited is 0.02 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Malibu Life Holdings Limited (MLHL)?
Earnings per share at Malibu Life Holdings Limited are $2.93 (price ÷ EPS = P/E 0.0). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Malibu Life Holdings Limited (MLHL)?
The net margin of Malibu Life Holdings Limited is 32.8% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Malibu Life Holdings Limited (MLHL)?
The return on equity (ROE) of Malibu Life Holdings Limited is 3.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Malibu Life Holdings Limited (MLHL)?
On an EBIT basis the return on assets of Malibu Life Holdings Limited is 2.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Malibu Life Holdings Limited (MLHL)?
The operating margin of Malibu Life Holdings Limited is −17.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Malibu Life Holdings Limited (MLHL)?
Revenue at Malibu Life Holdings Limited is growing −67.6% versus a year earlier (3y avg −13.3%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Malibu Life Holdings Limited (MLHL)?
Earnings per share at Malibu Life Holdings Limited are growing −76.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Malibu Life Holdings Limited (MLHL) hold?
Malibu Life Holdings Limited holds more cash than debt, $16.2M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Malibu Life Holdings Limited in the live analysis
One click puts Malibu Life Holdings Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
